4.7 Review

Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials

期刊

CANCER
卷 128, 期 11, 页码 2159-2173

出版社

WILEY
DOI: 10.1002/cncr.34165

关键词

acupuncture; adverse event; meta-analysis; neoplasms; randomized controlled trial; safety

类别

资金

  1. University of Duisburg-Essen

向作者/读者索取更多资源

This meta-analysis assessed the safety of acupuncture in oncological patients and found that acupuncture is as safe as sham acupuncture and active controls. Acupuncture does not increase the risk of intervention-related adverse events (AEs), serious AEs, or drop out because of AEs compared with sham acupuncture and active controls. Compared with treatment as usual (TAU), acupuncture does not increase the risk of intervention-related AEs, serious AEs, or drop out because of AEs, but is associated with an increased risk of non-serious AEs.
Background Acupuncture is frequently used to treat the side effects of cancer treatment, but the safety of this intervention remains uncertain. The current meta-analysis was conducted to assess the safety of acupuncture in oncological patients. Methods The PubMed, Cochrane Central Register of Controlled Trials, and Scopus databases were searched from their inception to August 7, 2020. Randomized controlled trials in oncological patients comparing invasive acupuncture with sham acupuncture, treatment as usual (TAU), or any other active control were eligible. Two reviewers independently extracted data on study characteristics and adverse events (AEs). Risk of bias was assessed using the Cochrane Risk of Bias Tool. Results Of 4590 screened articles, 65 were included in the analyses. The authors observed that acupuncture was not associated an with increased risk of intervention-related AEs, nonserious AEs, serious AEs, or dropout because of AEs compared with sham acupuncture and an active control. Compared with TAU, acupuncture was not associated with an increased risk of intervention-related AEs, serious AEs, or drop out because of AEs but was associated with an increased risk for nonserious AEs (odds ratio, 3.94; 95% confidence interval, 1.16-13.35; P = .03). However, the increased risk of nonserious AEs compared with TAU was not robust against selection bias. The meta-analyses may have been biased because of the insufficient reporting of AEs in the original randomized controlled trials. Conclusions The current review indicates that acupuncture is as safe as sham acupuncture and active controls in oncological patients. The authors recommend researchers heed the CONSORT (Consolidated Standards of Reporting Trials) safety and harm extension for reporting to capture the side effects and better investigate the risk profile of acupuncture in oncology. Lay Summary According to this analysis, acupuncture is a safe therapy for the treatment of patients with cancer. Acupuncture seems to be safe compared with sham acupuncture and active controls.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据